DJIA 17,086.63 -26.91 -0.16%
NASDAQ 4,473.70 17.68 0.40%
S&P 500 1,987.01 3.48 0.18%
market minute promo

company name or ticker
Company Photos
(Click to zoom)

Actavis Challenges Suboxone Film Patent - Analyst Blog

A Look at Actavis' Acquisitions - Analyst Blog

A Look at Actavis' Acquisitions - Analyst Blog

Can This Big Biotech Keep Outperforming Its Industry Peers?

Shares of Celgene have risen more than 100% over the past 12 months. Can it keep climbing, or is it time for investors to take profits?

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Profit Margin

Approval for Dr. Reddy's Generic Vidaza - Analyst Blog

US Stock Futures Edge Down Ahead Of Consumer Price Index

Dr. Reddy's Announces Azacitidine for Injection Approved by FDA

Dr. Reddy’s Announces the Approval of Azacitidine for Injection

Positive Outlook for the Generic Version of Depakote ER

Since 1983, Depakote ER has been a good source of revenue for drug manufacturers. But is its future as sunny?

Dr. Reddy's Launches Generic Depakote ER - Analyst Blog